Skip to Main Content

Paper Details

Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
Cancer Immunol Immunother
6
2022
Author NameAffiliation
Peter L ChoykeCenter for Cancer Research, National Cancer Institute
Hisataka KobayashiCenter for Cancer Research, National Cancer Institute
  • 1 - 2

Datasets

Release 1.2